Literature DB >> 19161079

Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population.

R Kelishadi1, M Gharipour, G H Sadri, A A Tavasoli, A Amani.   

Abstract

As part of the Isfahan Healthy Heart Program, we evaluated the prevalence of cardiovascular disease risk factors in Iranians with generalized and abdominal obesity. We carried out a cross-sectional study on 3694 > or = 19 years. Overall, 36.6% of men and 35.9% of women were overweight; 11.2% of men and 28.l% of women were obese. Mean body mass index (BMI), waist circumference (WC) and waist/hip ratio (WHR) increased with age up to 65 years. Total serum cholesterol, triglycerides and 2-hour post-load plasma glucose increased with BMI, WC and WHR in both sexes. Prevalence of metabolic syndrome was 19.8% in females with normal BMI, 48.1% in overweight females and 63.2% in obese females. In males, corresponding values were 3.7%, 18.0% and 40.1%.

Entities:  

Mesh:

Year:  2008        PMID: 19161079

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  14 in total

1.  Hypertension and Pre-Hypertension Among Iranian Adults Population: a Meta-Analysis of Prevalence, Awareness, Treatment, and Control.

Authors:  Roghaiyeh Afsargharehbagh; Khadije Rezaie-Keikhaie; Hosien Rafiemanesh; Abbas Balouchi; Salehoddin Bouya; Behroz Dehghan
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

2.  NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes.

Authors:  Nithya Mariappan; Carrie M Elks; Srinivas Sriramula; Anuradha Guggilam; Zhizhen Liu; Olga Borkhsenious; Joseph Francis
Journal:  Cardiovasc Res       Date:  2009-09-03       Impact factor: 10.787

3.  Is vitamin D status a determining factor for metabolic syndrome? A case-control study.

Authors:  Shabnam Salekzamani; Tirang R Neyestani; Hamid Alavi-Majd; Anahita Houshiarrad; Ali Kalayi; Nastaran Shariatzadeh; A'azam Gharavi
Journal:  Diabetes Metab Syndr Obes       Date:  2011-06-10       Impact factor: 3.168

4.  The impact of obesity on hypertension and diabetes control following healthy Lifestyle Intervention Program in a developing country setting.

Authors:  Aliakbar Tavassoli; Mojgan Gharipour; Nafiseh Toghianifar; Nizal Sarrafzadegan; Alireza Khosravi; Behzad Zolfaghari; Sonia Zarfeshani
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

5.  Metabolic syndrome and health-related quality of life in Iranian population.

Authors:  Nizal Sarrafzadegan; Mojgan Gharipour; Mohammad Arash Ramezani; Katayoun Rabiei; Behzad Zolfaghar; Ali Akbar Tavassoli; Maryam Boshtam; Sonia Zarfeshani; Alireza Khosravi; Alireza Yousefi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

Review 6.  Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review.

Authors:  Silva Hovsepian; Roya Kelishadi; Shirin Djalalinia; Farshad Farzadfar; Shohreh Naderimagham; Mostafa Qorbani
Journal:  J Res Med Sci       Date:  2015-05       Impact factor: 1.852

Review 7.  Coronary artery disease and its risk factors status in iran: a review.

Authors:  M Ebrahimi; S M R Kazemi-Bajestani; M Ghayour-Mobarhan; G A A Ferns
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

8.  Effect of age on the phenotype of metabolic syndrome in developing country.

Authors:  Mojgan Gharipour; Masoumeh Sadeghi; Mohsen Hosseini; Elham Andalib; Maraym Bakhtiari Boroujeni; Nizal Sarrafzadegan
Journal:  Adv Biomed Res       Date:  2015-05-29

Review 9.  Pivotal role of microRNA-33 in metabolic syndrome: A systematic review.

Authors:  Mojgan Gharipour; Masoumeh Sadeghi
Journal:  ARYA Atheroscler       Date:  2013-11

10.  The Prevalence of Cardiovascular Disease Risk Factors among Employees in the Kingdom of Bahrain between October 2010 and March 2011: A Cross-Sectional Study from a Workplace Health Campaign.

Authors:  Ameera Ali Al-Nooh; Abdulhussain Abdulabbas Abdulla Alajmi; David Wood
Journal:  Cardiol Res Pract       Date:  2014-07-06       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.